Phase ii trial of upfront bevacizumab, irinotecan, and temozolomide for unresectable glioblastoma

  • Katherine B. Peters
  • , Emil Lou
  • , Annick Desjardins
  • , David A. Reardon
  • , Eric S. Lipp
  • , Elizabeth Miller
  • , James E. Herndon
  • , Frances McSherry
  • , Henry S. Friedman
  • , James J. Vredenburgh

Research output: Contribution to journal › Article › peer-review

32 Scopus citations

Fingerprint

Dive into the research topics of 'Phase ii trial of upfront bevacizumab, irinotecan, and temozolomide for unresectable glioblastoma'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience